Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to treating many types of cancer. However, it doesn't work well for some tumors, ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

1 Yibin Institute of Traditional Chinese Medicine, Yibin, Sichuan, China 2 Yibin Hospital of Traditional Chinese Medicine, Yibin, Sichuan, China Epithelial ovarian cancer (EOC) remains a lethal ...

LONDON, Oct 15 (Reuters) - German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round to date, contributing to a total of 495 million ...

The Texas-based company announced on Tuesday that its research collaborators will present preclinical data at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ...

"The shining star of our family has dimmed his light for us in this life," his family said. By Ethan Millman Music Editor D’Angelo, the Grammy-winning R&B icon who helped launch neo soul in the ’90s, ...

To improve the quality of life of people with cancer, oncologists have regularly recommended exercise. Staying fit can make patients feel and function better. But exercise itself was never considered ...

Soul legend D’Angelo has died after a private battle with pancreatic cancer. He was 51. “The shining star of our family has dimmed his light for us in this life,” his family said in a statement to Us ...

A newly uncovered mechanism thought to be a weakness of prostate cancer cells could inspire a new and improved targeted treatment for the disease. International research led by Flinders University in ...

HOLON, Israel, Oct. 13, 2025 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men. The research, published in the ...